VNRX
VolitionRx Limited
1W: +1.6%
1M: -20.6%
3M: -24.2%
YTD: -29.3%
1Y: -65.1%
3Y: -88.6%
5Y: -94.4%
$0.19
+0.00 (+0.89%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$19.2M
52W Range0.17-0.94
Volume9,789,772
Avg Volume8,428,569
Beta1.36
Dividend—
Analyst Ratings
Company Info
CEOCameron Reynolds
Employees85
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2012-03-02
Websitevolition.com
13215 Bee Cave Parkway
Henderson, TX 78738
US
Henderson, TX 78738
US
646 650 1351
About VolitionRx Limited
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Latest News
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
VolitionRx Achieves >99% Pure Tumor-Derived DNA Isolation With Novel ChIP-Seq Liquid Biopsy Technology, Advancing Early Cancer Detection
Zacks Research Has Optimistic View of VolitionRx Q4 Earnings
VNRX: Review of Recent Events by Pillar; 4Q & Year End 2025 Results Expected in late March; Special Meeting of Stockholders to be held on March 31st to approve reverse-split. Almost US$2 million in cash funding received through the issuance of Convertible Note.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Forterre Gael | F-InKind | 5,251 | $0.19 | 2026-03-17 |
| Rootsaert Rodney Ger | F-InKind | 3,948 | $0.19 | 2026-03-17 |
| Micallef Jacob Vince | F-InKind | 5,310 | $0.19 | 2026-03-17 |
| Plummer Nicholas | F-InKind | 7,003 | $0.19 | 2026-03-17 |
| Rootsaert Rodney Ger | F-InKind | 3,321 | $0.21 | 2026-03-01 |